The effect of influenza virus on the human oropharyngeal microbiome

Clinical Infectious Diseases

Volumn 68, Issue 12, 2019, Pages 1993-2002

  Ramos Sevillano, Elisa ^a   Wade, William G ^b   Mann, Alex ^c   Gilbert, Anthony ^c   Lambkin Williams, Robert ^c   Killingley, Ben ^d   Nguyen Van Tam, Jonathan S ^e   Tang, Christoph M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Queen Mary BioEnterprises Innovation Centre   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Influenza; Microbiome; Upper respiratory tract

Indexed keywords

RNA 16S;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DNA ISOLATION; EXPERIMENTAL INFLUENZA; GENE AMPLIFICATION; HUMAN; INFLUENZA A (H3N2); INFLUENZA VIRUS; INOCULATION; MAJOR CLINICAL STUDY; MICROBIAL COMMUNITY; MICROFLORA; NEISSERIA MENINGITIDIS; OROPHARYNX MICROBIOME; PATIENT MONITORING; PRIORITY JOURNAL; PYROSEQUENCING; SEQUENCE ANALYSIS; STREPTOCOCCUS PNEUMONIAE; BIODIVERSITY; CASE CONTROL STUDY; GENETICS; INFLUENZA; METAGENOME; METAGENOMICS; MICROBIOLOGY; ORGANISMAL INTERACTION; OROPHARYNX; ORTHOMYXOVIRIDAE; PROCEDURES;

BIODIVERSITY; CASE-CONTROL STUDIES; HUMANS; INFLUENZA, HUMAN; METAGENOME; METAGENOMICS; MICROBIAL INTERACTIONS; MICROBIOTA; OROPHARYNX; ORTHOMYXOVIRIDAE; RNA, RIBOSOMAL, 16S;

EID: 85059644795     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciy821     Document Type: Article

References (44)

1. Smith AM, McCullers JA. Secondary bacterial infections in influenza virus infection pathogenesis. Curr Top Microbiol Immunol 2014; 385:327–56.
2. st century. J Infect Dis 2007; 195:1018–28.
3. Sheng ZM, Chertow DS, Ambroggio X, et al. Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proc Natl Acad Sci USA 2011; 108:16416–21.
4. Lee EH, Wu C, Lee EU, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010; 50:1498–504.
5. Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancet 1933; 2:66–8.
6. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19:571–82.
7. Murray RJ, Robinson JO, White JN, et al. Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection. PLoS One 2010; 5:e8705.
8. Cartwright KA, Jones DM, Smith AJ, Stuart JM, Kaczmarski EB, Palmer SR. Influenza A and meningococcal disease. Lancet 1991; 338:554–7.
9. Bakaletz LO. Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 1995; 3:110–4.
10. Murphy TF, Bakaletz LO, Smeesters PR. Microbial interactions in the respiratory tract. Pediatr Infect Dis J 2009; 28:S121–6.
11. McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 2014; 12:252–62.
12. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 2005; 192:249–57.
13. Shakhnovich EA, King SJ, Weiser JN. Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract. Infect Immun 2002; 70:7161–4.
14. Nita-Lazar M, Banerjee A, Feng C, et al. Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding. Mol Immunol 2015; 65:1–16.
15. Quattroni P, Li Y, Lucchesi D, et al. Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells. Cell Microbiol 2012; 14:1657–75.
16. Siegel SJ, Roche AM, Weiser JN. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 2014; 16:55–67.
17. Faust K, Raes J. Microbial interactions: from networks to models. Nat Rev Microbiol 2012; 10:538–50.
18. Charlson ES, Chen J, Custers-Allen R, et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One 2010; 5:e15216.
19. Biesbroek G, Wang X, Keijser BJ, et al. Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis 2014; 20:201–10.
20. Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010; 5:e9836.
21. Huang YJ, Lynch SV, Wiener-Kronish JP. From microbe to microbiota: considering microbial community composition in infections and airway diseases. Am J Respir Crit Care Med 2012; 185:691–2.
22. de Steenhuijsen Piters WA, Huijskens EG, Wyllie AL, et al. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J 2016; 10:97–108.
23. Zhao J, Schloss PD, Kalikin LM, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 2012; 109:5809–14.
24. Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol 2014; 52:2813–23.
25. Yi H, Yong D, Lee K, Cho YJ, Chun J. Profiling bacterial community in upper respiratory tracts. BMC Infect Dis 2014; 14:583.
26. Allen EK, Koeppel AF, Hendley JO, Turner SD, Winther B, Sale MM. Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome 2014; 2:22.
27. Kistler JO, Booth V, Bradshaw DJ, Wade WG. Bacterial community development in experimental gingivitis. PLoS One 2013; 8:e71227.
28. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75:7537–41.
29. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011; 27:2194–200.
30. Chao A. Nonparametric-estimation of the number of classes in a population. Scand J Stat 1984; 11:265–70.
31. Bunge J. Estimating the number of species with CatchAll. Pac Symp Biocomput 2011:121–30.
32. Simpson EH. Measurement of diversity. Nature 1949; 163:688-688.
33. Shannon CE. A mathematical theory of communication. Bell Syst Tech J 1948; 27: 379–423.
34. Good IJ. The population frequencies of species and the estimation of population parameters. Biometrika 1953; 40:237–64.
35. Yue JC, Clayton MK. A similarity measure based on species proportions. Commun Stat Theory Methods 2005; 34:2123–31.
36. Lozupone CA, Knight R. Species divergence and the measurement of microbial diversity. FEMS Microbiol Rev 2008; 32:557–78.
37. Bennett JS, Watkins ER, Jolley KA, Harrison OB, Maiden MC. Identifying Neisseria species by use of the 50S ribosomal protein L6 (rplF) gene. J Clin Microbiol 2014; 52:1375–81.
38. Carvalho Mda G, Tondella ML, McCaustland K, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 2007; 45:2460–6.
39. Excoffier L, Smouse PE, Quattro JM. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 1992; 131:479–91.
40. Slatkin M, Maddison WP. Detecting isolation by distance using phylogenies of genes. Genetics 1990; 126:249–60.
41. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60.
42. Chaban B, Albert A, Links MG, Gardy J, Tang P, Hill JE. Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza. PLoS One 2013; 8:e69559.
43. Kugelberg E, Gollan B, Farrance C, et al. The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease. PLoS One 2010; 5:e9413.
44. Lehtinen MJ, Hibberd AA, Männikkö S, et al. Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge. Sci Rep 2018; 8:11411.